<DOC>
	<DOCNO>NCT02539433</DOCNO>
	<brief_summary>Imaging neuroendocrine ( NETs ) , carcinoid pheochromocytomas ( PHEOs ) , suboptimal , limit curative treatment . The investigator want explore use PET F-DOPA i.v . localization type neoplasms . The investigator use similar protocol use PET ( Positron emission tomography ) FDG ( Fludeoxyglucose ) image oncologic patient . F-DOPA , prepare accord United States Pharmacopeia ( USP ) guideline , approve North Shore University Hospital Radiation Safety Committee 1989 1994 study neurological disease use uneventfully .</brief_summary>
	<brief_title>Imaging Neuroendocrine Tumors With PET Fluoro-18-DOPA ( F-DOPA )</brief_title>
	<detailed_description>Background : Pre surgical conventional image neuroendocrine tumor ( NETs ) CT , MRI , In-111 octreotide 1-123-MIBG ( metaiodobenzylguanidine ) scintigraphy limitation . This pilot study try improve localization tumor F-18-F-DOPA PET scan . Methods : The investigator study 22 patient , majority refer clinical diagnosis carcinoid ( 9 ) NETs ( 9 ) pheochromocytoma/paraganglioma ( 3 ) . Carbidopa administer prior F-DOPA injection 12 patient . Comparison make prior conventional imaging . The F-DOPA finding , read blindly findings modality , compare result subsequent surgery ( 2 ) , endoscopy ( 1 ) , long-term follow mean duration 49 month ( 20 patient ) . Two subject lose follow-up .</detailed_description>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Dihydroxyphenylalanine</mesh_term>
	<criteria>23 year age old Appropriate diagnosis refer physician Less 23 year age Greater 81 year age Pregnancy Lactation Prior history radiation treatment Chemotherapy antituberculosis medication .</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>